Last Modified: September 7, 2010
Conference Dates: October 16, 2010
Conference Location: The Westin New York at Times Square - 270 W. 43rd St. at 8th Ave., New York, NY 10036
Sponsoring Group: Physicians' Education Resource
Conference Web Page URL: www.cancerlearning.com/index.cfm/fuseaction/conference.showOverview/id/5/conference_id/589
Topics Covered: androgen deprivation therapy, ADT, cancer symposium, cancer meeting, localized prostate cancer, PSA relapse, immunotherapy, sipuleucel-T, castrate resistant prostate cancer, CRPC, androgen independent prostate cancer, managing recurrent prostate cancer, cabazitaxel, neoadjuvant therapy, adjuvant therapy, surgery in renal cell carcinoma, renal cell carcinoma, RCC, MSKCC risk criteria, RCC treatment algorithm, antiangiogenic therapy, hormonal therapy, bone metastasis, cancer therapy induced bone disease, bone loss, CTIBD, chemotherapy in bladder cancer, targeted therapy in bladder cancer, combination therapy in bladder cancer, TCC, transitional cell cancer, urothelial carcinoma, sequential therapy in RCC, sequential therapy, combination therapy in RCC, managing refractory RCC, angiogenic escape, frontline manangement of advanced/metastatic RCC, non-clear cell RCC, non-clear cell renal cell carcinoma,kidney cancer, clear cell, non-clear cell, testicular cancer, seminoma, stage I seminoma, partial nephrectomy, cryosurgery, cryoablation, tumor board
Conference Objectives: Inform participants of the latest advances in the treatment of genitourinary malignancies and to promote their integration into the practice setting as well as to describe future directions in research and clinical trials.
Who Should Attend: medical, surgical, and radiation oncologists; urologists; internal medicine and primary care physicians; and basic research investigators interested in the treatment and management of patients with kidney, bladder, prostate, and testicular cancers. Fellows, oncology nurses, oncology physician assistants, and pharmacists interested in the treatment of genitourinary malignancies are also invited to attend.
Registration Information: Phone (888) 949-0045 Fax (214) 367-3402 CustomerSupport@CancerLearning.com
Conference Fees: $75.00
Continuing Education: Yes